Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Reinventing fine chemicals synthesis: large-scale production of sparteine from lupin beans

Project description

Delivering unlimited amounts of the natural compound Sparteine to pharma and academia

Sparteine’s potential, especially for the pharmaceutical industry, has yet to be exploited because it is expensive and difficult to get on the market in bulk amount. Portugal-based Spartax Chemicals introduced a novel method to widely produce enantiomerically pure Sparteine by using a compound obtained from the wastewater of lupin processing. The cost-efficient process could supply Sparteine in large amounts while reducing production costs and delivering non-stop production. The EU-funded SpartWISE project will explore the technical and financial feasibility and market potential of extensively producing and commercialising Sparteine. To do so, it will assess all scale-up costs, research potential customers and deliver a business plan for commercialisation.

Objective

Spartax Chemicals, a newly founded Portuguese company, has developed an innovative process for the large scale production of Sparteine, using as raw material a compound extracted from lupin processing wastewater. Enantiomerically pure sparteine is an exceptionally good enantioselective ligand for asymmetric synthesis that has found application not only in the field of synthetic organic chemistry but also in the development of synthetic routes for the preparation of commercial drugs and drug candidates, with the most prominent example being the anticonvulsant drug (S)-Pregabalin.
The SpartWISE process was developed to address the market need for reliable sources of both enantiomers of Sparteine. It is a well-documented fact that there is a cyclic stock rupture of enantiomerically pure Sparteine at the main chemical vendors. As a consequence, many researchers, both from academia and industry, have been forced to look inter alia for suppliers in the Asian market, which often do not comply with the standards of quality necessary for R&D purposes, or do not deliver the requested product in sufficient amount in due time.
Contrary to the state of the art approach, which relies on the cumbersome extraction and purification of small amounts of (-)-Sparteine available from a leguminous shrub, the SpartWISE technology offers a cost-effective process that can make this compound available on kilogram-scale with drastic reduction of production costs and with continuous production. Moreover, it also generates the even scarcer enantiomer (+)-Sparteine.
Our goal for the Phase 1 is to assess the feasibility and market potential for the large scale production and commercialisation of Sparteine. For that purpose, we will (a) assess all the costs of the scaling-up, (b) investigate the prospective customers for our products and (c) develop a detailed business plan for commercialisation.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

SPARTAX CHEMICALS, LDA
Net EU contribution
€ 50 000,00
Address
AVENIDA 25 DE ABRIL, N 6, 1 DTO (JA
2620-185 RAMADA E CANECAS
Portugal
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00